search    contact us
THE DANGER
THE VACCINE
THE PRIORITY
THE STRATEGY
adverse event info
education toolkit
resource center
my vaccination
smallpox overview

Last Updated:
13 Aug 09
header image

 RESOURCE CENTER: Vaccine & VIG Information

    sitemap    home
title
seperator
  arrow What's New
seperator
  arrow Forms
seperator
  arrow Images 
seperator
  arrow Library
seperator
  arrow News
seperator
  arrow Policies
seperator
  arrow Q & A
seperator
  arrow Related Links
seperator
  arrow Service Messages
seperator
  arrow Smallpox Planning Docs
seperator
  arrow Supply & Logisics
seperator
  arrow Vaccine & VIG Info
seperator


 Vaccine Deployment Guidance - ACAM2000 PDF  24 Mar 08
   

 ACAM2000 Vial Stopper Raw Material Content PDF  14 Mar 08
   Latex-free Stopper Information Letter

 ACAM2000 Expiration Chart PDF  29 Feb 08
   Conversion table detailing 17 months expiration dating from date of shipment

 Medication Guide - ACAM2000™ PDF  16 Jan 08
   Smallpox (Vaccinia) Vaccine, Live

 Dryvax/ACAM2000 Comparison Chart PDF  11 Jan 08
   

 Smallpox Vaccine Extension of Dating PDF  21 Dec 07
   Lot # 4020072
Lot # 4020074
Lot # 4020075
Lot # 4020076
Lot # 4020077
Lot # 4030013
Lot # 4030014
Lot # 4030020

The dating will be extended from 31 Dec 07 until 29 Feb 08 at which time Wyeth intends to withdraw all vaccine from the field.

Dryvax is stable for 90 days after reconstitution, if refrigerated.

 Intra-Venous Vaccinia Immune Globulin (IV-VIG) PDF  9 Nov 07
   Information Paper

 Dryvax (Wyeth)
   Package Insert

 FDA Questions and Answers
   ACAM2000TM Smallpox (Vaccinia) Vaccine, Live

 FDA Product Approval Letter
   Smallpox (Vaccinia) Vaccine, Live - ACAM2000

 Vaccinia Immune Globulin Intravenous (Human) (VIGIV) (Cangene)
   Package Insert

 Smallpox Vaccine Storage and Handling
   An interactive, Internet-based training course sponsored by the CDC's National Immunization Program (NIP)

 Risk Communication Plan for Health Care Facilities PDF  29 Dec 03
   

 Notice to Readers:
   Guidelines for Maintaining and Managing the Vaccine Cold Chain

 Expected Appearance of Dryvax-brand Smallpox Vaccine PDF  5 Mar 03
   Author: Col. John D. Grabenstein, Maj Patrick Garman

 Revised Stability Information PDF  13 Feb 03
   Dryvax is stable for 90 days after reconstitution, if refrigerated.

 Lot Release Information for Dryvax Lot 4020071  PDF  25 Oct 02